These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 31486388)

  • 1. Incidence of Euglycemic Diabetic Ketoacidosis in Adults With Type 1 Diabetes in the United Kingdom Before the Widespread Use of Sodium Glucose Cotransporter 2 Inhibitors.
    Macfarlane J; Dhatariya K
    Mayo Clin Proc; 2019 Sep; 94(9):1909-1910. PubMed ID: 31486388
    [No Abstract]   [Full Text] [Related]  

  • 2. Euglycemic diabetic ketoacidosis.
    González-Castro A; Ortiz Lasa M; Jiménez Alfonso A
    Med Clin (Barc); 2019 May; 152(10):416-417. PubMed ID: 30017208
    [No Abstract]   [Full Text] [Related]  

  • 3. Sodium–glucose co-transporter 2 inhibitors: Think twice about diabetic ketoacidosis.
    Markey AG; Scott TA; Killen JC; Venter JA
    Aust J Gen Pract; 2018 Apr; 47(4):223-225. PubMed ID: 29621864
    [No Abstract]   [Full Text] [Related]  

  • 4. Euglycemic Ketoacidosis With Sodium-Glucose Cotransporter-2 Inhibitor.
    Koch RA; Clark RF
    Am J Ther; 2018; 25(5):e590-e591. PubMed ID: 28452848
    [No Abstract]   [Full Text] [Related]  

  • 5. Frequency and clinical characteristics of ketoacidosis at onset of childhood type 1 diabetes mellitus in Northwest Saudi Arabia.
    Habib HS
    Saudi Med J; 2005 Dec; 26(12):1936-9. PubMed ID: 16380776
    [TBL] [Abstract][Full Text] [Related]  

  • 6. First Case Report of Euglycemic Diabetic Ketoacidosis With an Automated Insulin Pump in a 12-Year-Old Patient With Type 1 Diabetes Mellitus.
    Phung K; Henderson M; Geoffroy L
    Can J Diabetes; 2022 Feb; 46(1):81-83. PubMed ID: 34303620
    [No Abstract]   [Full Text] [Related]  

  • 7. Sodium-glucose cotransporter 2 inhibitor-induced euglycemic diabetic ketoacidosis in a patient with coronavirus disease 2019: a case report.
    Yii ESS; Azli AW; Sitaram PN
    J Med Case Rep; 2022 Jan; 16(1):17. PubMed ID: 34983625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sodium-glucose cotransporter 2 inhibitor-associated diabetic ketoacidosis in patients with type 1 diabetes: Metabolic imbalance as an underlying mechanism.
    Ogawa W; Hirota Y
    J Diabetes Investig; 2019 Jul; 10(4):879-882. PubMed ID: 30768861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sodium-glucose cotransporter-2-induced euglycemic diabetic ketoacidosis unmasks latent autoimmune diabetes in a patient misdiagnosed with type 2 diabetes mellitus: a case report.
    Vadasz B; Arazi M; Shukha Y; Koren O; Taher R
    J Med Case Rep; 2021 Feb; 15(1):62. PubMed ID: 33581735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Use of Sodium-Glucose Cotransporter 2 Inhibitors in Patients With Type 1 Diabetes and Rates of Diabetic Ketoacidosis.
    Hampp C; Swain RS; Horgan C; Dee E; Qiang Y; Dutcher SK; Petrone A; Chen Tilney R; Maro JC; Panozzo CA
    Diabetes Care; 2020 Jan; 43(1):90-97. PubMed ID: 31601640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SGLT2 Inhibitors and Euglycemic Ketoacidosis.
    Masuta P; Johri G; Paul M
    Am J Ther; 2018; 25(4):e498-e500. PubMed ID: 28537992
    [No Abstract]   [Full Text] [Related]  

  • 12. Real life evaluation of sodium-glucose cotransporter 2 inhibition in type 1 diabetes and the risk of diabetic ketoacidosis.
    Stougaard EB; Kristensen PL; Kielgast U; Andersen HU; Hamid Y; Gæde PH; Søndergaard E; Dørflinger GH; Fjeldborg KK; Hansen KW; Thomsen HH; Al-Imar TMJ; Røder M; Sridhar VS; Cherney D; Rossing P; Persson F
    Diab Vasc Dis Res; 2022; 19(5):14791641221130043. PubMed ID: 36262089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Uncovering Autoimmune Diabetes in a Patient With Euglycemic Diabetic Ketoacidosis.
    Schempf J; Chow LS; Harindhanavudhi T
    Am J Med Sci; 2020 Sep; 360(3):307-308. PubMed ID: 32536417
    [No Abstract]   [Full Text] [Related]  

  • 14. Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations on the use of sodium-glucose cotransporter inhibitors with insulin for treatment of type 1 diabetes (Updated October 2020).
    Dashora U; Patel DC; Gregory R; Winocour P; Dhatariya K; Rowles S; Macklin A; Rayman G; Nagi D;
    Diabet Med; 2021 Feb; 38(2):e14458. PubMed ID: 33179277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and Clinical Characteristics of Adults Presenting With Sodium-Glucose Cotransporter-2 Inhibitor-Associated Diabetic Ketoacidosis at a Canadian Academic Tertiary Care Hospital.
    Clark A; Mohammed AS; Raut A; Moore S; Houlden R; Awad S
    Can J Diabetes; 2021 Apr; 45(3):214-219. PubMed ID: 33046401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diabetic Ketoacidosis With Canagliflozin, a Sodium-Glucose Cotransporter 2 Inhibitor, in Patients With Type 1 Diabetes.
    Peters AL; Henry RR; Thakkar P; Tong C; Alba M
    Diabetes Care; 2016 Apr; 39(4):532-8. PubMed ID: 26989182
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Case Report of Diabetic Ketoacidosis With Combined Use of a Sodium Glucose Transporter 2 Inhibitor and Hybrid Closed-Loop Insulin Delivery.
    Singh S; Rushakoff RJ; Neinstein AB
    J Diabetes Sci Technol; 2019 May; 13(3):605-606. PubMed ID: 30931610
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges in the Diagnosis of Euglycemic Diabetic Ketoacidosis in a Patient With Multiple Sclerosis Taking a Sodium-Glucose Cotransporter 2 Inhibitor.
    Allison R; Goldstein D; Musso MW
    J Emerg Med; 2019 Jul; 57(1):e1-e3. PubMed ID: 31027990
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetic ketoacidosis in patients under treatment with sodium-glucose cotransporter type 2 inhibitors.
    López Medina JA; Hernández García C; Espíldora Hernández J
    Med Clin (Barc); 2017 Oct; 149(7):311-312. PubMed ID: 28662890
    [No Abstract]   [Full Text] [Related]  

  • 20. Joint British Diabetes Societies guideline for the management of diabetic ketoacidosis.
    Savage MW; Dhatariya KK; Kilvert A; Rayman G; Rees JA; Courtney CH; Hilton L; Dyer PH; Hamersley MS;
    Diabet Med; 2011 May; 28(5):508-15. PubMed ID: 21255074
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.